In development: Guidance, quality standards and advice
Showing 1 to 7 of 7
Title | Type | Expected publication date |
---|---|---|
Canagliflozin for treating chronic kidney disease in people with type 2 diabetes [ID1653] | Technology appraisal guidance | TBC |
Dapagliflozin for treating chronic kidney disease [ID6411] | Technology appraisal guidance | TBC |
Daprodustat for treating anaemia in people with chronic kidney disease [ID3987] | Technology appraisal guidance | TBC |
Kidney Cancer | Quality standard | TBC |
Kidney Cancer | NICE guideline | TBC |
Letermovir for preventing cytomegalovirus infection after a kidney transplant [ID6166] | Technology appraisal guidance | TBC |
Vadadustat for treating symptomatic anaemia in adults having dialysis for chronic kidney disease [ID3821] | Technology appraisal guidance |